tiprankstipranks
Trending News
More News >
Xilio Therapeutics Inc (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Cash flow

Compare
212 Followers

Xilio Therapeutics Cash Flow

XLO's free cash flow for Q3 2025 was $-17.50M. For the 2025 fiscal year, XLO's free cash flow was decreased by $50.69M and operating cash flow was $-17.50M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -18.38M$ -68.62M$ -75.72M$ -80.75M$ -36.09M
Investing Cash Flow
$ -36.00K$ -486.00K$ -1.87M$ -1.10M$ -2.19M
Financing Cash Flow
$ 29.20M$ -6.55M$ -69.00K$ 260.67M$ 10.03M
End Cash Position
$ 57.07M$ 44.70M$ 120.39M$ 199.61M$ 20.79M
Free Cash Flow
$ -18.41M$ -69.11M$ -77.59M$ -81.85M$ -38.28M
Currency in USD

Xilio Therapeutics Cash Flow